237 related articles for article (PubMed ID: 29271248)
1. Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers.
Nakken O; Lindstrøm JC; Tysnes OB; Holmøy T
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):303-310. PubMed ID: 29271248
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
[TBL] [Abstract][Full Text] [Related]
3. Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study.
Nakken O; Lindstrøm JC; Tysnes OB; Holmøy T
J Neurol; 2016 Dec; 263(12):2378-2385. PubMed ID: 27586392
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
[TBL] [Abstract][Full Text] [Related]
5. Increasing mortality from amyotrophic lateral sclerosis in Norway?
Seljeseth YM; Vollset SE; Tysnes OB
Neurology; 2000 Nov; 55(9):1262-6. PubMed ID: 11087765
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.
Kioumourtzoglou MA; Seals RM; Himmerslev L; Gredal O; Hansen J; Weisskopf MG
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):224-9. PubMed ID: 25946516
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.
Kioumourtzoglou MA; Rotem RS; Seals RM; Gredal O; Hansen J; Weisskopf MG
JAMA Neurol; 2015 Aug; 72(8):905-11. PubMed ID: 26030836
[TBL] [Abstract][Full Text] [Related]
8. [Causes of death in amyotrophic lateral sclerosis : Results from the Rhineland-Palatinate ALS registry].
Wolf J; Safer A; Wöhrle JC; Palm F; Nix WA; Maschke M; Grau AJ
Nervenarzt; 2017 Aug; 88(8):911-918. PubMed ID: 28184974
[TBL] [Abstract][Full Text] [Related]
9. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation.
Tollefsen E; Midgren B; Bakke P; Fondenes O
Eur J Neurol; 2010 Nov; 17(11):1352-7. PubMed ID: 20443984
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study.
Vázquez MC; Ketzoián C; Legnani C; Rega I; Sánchez N; Perna A; Penela M; Aguirrezábal X; Druet-Cabanac M; Medici M
Neuroepidemiology; 2008; 30(2):105-11. PubMed ID: 18334826
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.
Chiò A; Magnani C; Oddenino E; Tolardo G; Schiffer D
J Epidemiol Community Health; 1992 Oct; 46(5):517-8. PubMed ID: 1479322
[TBL] [Abstract][Full Text] [Related]
13. Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics.
Bhattacharya R; Harvey RA; Abraham K; Rosen J; Mehta P
Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):251-259. PubMed ID: 30892090
[No Abstract] [Full Text] [Related]
14. Incidence and clinical features of amyotrophic lateral sclerosis in Møre and Romsdal County, Norway.
Gundersen MD; Yaseen R; Midgard R
Neuroepidemiology; 2011; 37(1):58-63. PubMed ID: 21860251
[TBL] [Abstract][Full Text] [Related]
15. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015.
Punjani R; Wagner L; Horton K; Kaye W
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):123-130. PubMed ID: 31795746
[TBL] [Abstract][Full Text] [Related]
16. Validating population-based registers for ALS: how accurate is death certification?
Yeo L; Lynch C; Hardiman O
J Neurol; 2010 Aug; 257(8):1235-9. PubMed ID: 20151145
[TBL] [Abstract][Full Text] [Related]
17. Validity of death certificates in the identification of cases of amyotrophic lateral sclerosis (ALS) in the Limousin region, France. A population-based study.
Baldin E; Preux PM; Couratier P; Pugliatti M; Marin B;
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):228-234. PubMed ID: 32276555
[No Abstract] [Full Text] [Related]
18. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002-2014: a retrospective population-based study.
Palese F; Sartori A; Verriello L; Ros S; Passadore P; Manganotti P; Barbone F; Pisa FE
Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):90-99. PubMed ID: 30430867
[TBL] [Abstract][Full Text] [Related]
19. Place of death and associated factors among patients with amyotrophic lateral sclerosis in Madrid (Spain).
Domínguez-Berjón MF; Esteban-Vasallo MD; Zoni AC; Gènova-Maleras R; Astray-Mochales J
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):62-8. PubMed ID: 26473583
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000-2015: prevalence, incidence, and clinical features.
Benjaminsen E; Alstadhaug KB; Gulsvik M; Baloch FK; Odeh F
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):522-527. PubMed ID: 30265157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
